首页> 外国专利> Preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine (lamotrigene), useful for treating epilepsy, starting from 2,3-dichloronitrobenzene

Preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine (lamotrigene), useful for treating epilepsy, starting from 2,3-dichloronitrobenzene

机译:从2,3-二氯硝基苯开始制备6-(2,3-二氯苯基)-1,2,4-三嗪-3,5-二胺(拉莫三基因)

摘要

A new process for the preparation of 6-(2,3-dichlorophenyl-1,2,4-triazine-3,5-diamine (lamotrigene) starting from 2,3-dichloronitrobenzene is disclosed. A novel process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine (lamotrigine) of formula (I), comprises: (a) reduction of the 2,3-dichloronitrobenzene in 1-6C aliphatic alkanol with H2 gas at a pressure of 55-90 psi in the presence of a metal catalyst at 27-35[deg]C; (b) diazotization of the resulting 2,3-dichloroaniline with sodium nitrite and a mineral acid at -5[deg]C to 5[deg]C followed by cyano-de-diazonation with a metal cyanide at 65-80[deg]C; (c) hydrolysis of the resulting 2,3-dichlorobenzonitrile under acidic or alkaline conditions; (d) chlorination of the resulting 2,3-dichlorobenzoic acid with a chlorinating agent at 55-130[deg]C; (e) cyano-de-halogenation of the resulting 2,3-dichloro-benzoyl with a metal cyanide in the presence of an alkali metal iodide by refluxing in an aprotic solvent under an inert atmosphere; (f) condensation of the resulting 2,3-dichlorobenzoyl cyanide with aminoguanidine bicarbonate in an organic solvent in acidic conditions in the presence of a catalyst at 90-125[deg]C followed by in situ cyclization of the resulting Schiff's base of formula (IV): by refluxing in an aliphatic alkanol in the presence of a base; and (g) purification of the resulting crude lamotrigine of formula (I) by a known method such as recrystallization from an aliphatic alkanol or chromatographic separation. [Image] ACTIVITY : Anticonvulsant; Neuroprotective. MECHANISM OF ACTION : Inhibitor of the release of excitatory neurotransmitter.
机译:公开了一种从2,3-二氯硝基苯开始制备6-(2,3-二氯苯基-1,2,4-三嗪-3,5-二胺(拉莫三基因)的新方法。式(I)的-(2,3-二氯苯基)-1,2,4-三嗪-3,5-二胺(拉莫三嗪),包括:(a)在1-6C脂族烷醇中还原2,3-二氯硝基苯。在金属催化剂存在下于27-35℃下用H2气体在55-90 psi的压力下进行;(b)在-5 []下用亚硝酸钠和无机酸将所得的2,3-二氯苯胺重氮化。 ℃至5℃,然后在65-80℃下用金属氰化物进行氰基脱重氮;(c)在酸性或碱性条件下水解所得的2,3-二氯苄腈;(d)在55-130℃下用氯化剂氯化所得的2,3-二氯苯甲酸;(e)在存在下的条件下,将所得的2,3-二氯苯甲酰基与金属氰化物氰基脱卤化。碱金属碘化物,在非质子溶剂中回流惰性气氛(f)在酸性条件下,在催化剂存在下,在90-125℃下,在有机溶剂中将所得的2,3-二氯苯甲酰氰与氨基胍碳酸氢盐缩合,然后将所得的式(7)的席夫碱原位环化。 IV):在碱的存在下在脂族链烷醇中回流; (g)通过已知方法,例如从脂肪族链烷醇中重结晶或色谱分离,纯化所得的式(I)粗制拉莫三嗪。 [图像]活动:抗惊厥药;具有神经保护作用。作用机理:抑制兴奋性神经递质的释放。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号